1 Global New Employee Orientation Workshop Welcome.
-
Upload
daisy-marshall -
Category
Documents
-
view
219 -
download
0
Transcript of 1 Global New Employee Orientation Workshop Welcome.
1
Global New Employee Orientation Workshop
Welcome
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
2Recruiting
InterviewingJob Offer and Acceptance
Receipt of Welcome Packet
New Employee Orientation Workshop
Intranet Orientation Site
On-the-job Experience and Training
Job-specific Training
On-going Networking and Social Events
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
3
Workshop Agenda
Welcome
Participant Introductions
Document Completion
Benefits Information
A Pharmaceutical Company History Video
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
4
Workshop Agenda (continued)
Company Overview
Red Book and Asset Protection
Performance Management/Career Development
Workshop Summary
Wrap-up and Evaluation
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
5
Workshop Objectives
To let you know:
• What is expected of you
• How to add value to the company
• How to communicate with your colleagues
• How to integrate as team players
6
Company Overview
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
7
A Pharmaceutical Company’s Global Presence
• Employs more than 31,000 people
• Has Research and Development facilities in 9 countries
• Markets medicines in 179 countries
Around the world, A Pharmaceutical Company:
• Has Manufacturing facilities in 20 countries
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
8
Our Three Core Values
Respect for people
Integrity
Thirst for excellence
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
9
Our Mission
Enable people to live longer, healthier, more active lives
A Pharmaceutical Company is a research-based global company
Creates pharmaceutical-based health care solutions
That
To
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
10
People
Scientific Innovation
Demand Realization
Shareholder Value
Our Four Corporate Objectives
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
11
Our Organizational Structure
Policy Committee Charter
At the corporate level, approve and own:
• Performance targets
• Strategies
• Policies
Ensure compliance
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
12
Our Organizational Structure
Policy Committee Activities:
Manage corporate strategy
Allocate resources
Manage corporate assets
Review investments
Review organizational policies
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
13
Our Organizational Structure
Operations Committee Charter
Integrate strategies based on:
• Product
• Geography
• Function
Monitor corporate performance
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
14
Our Organizational Structure
Operations Committee CharterIdentify and discuss corporate:
• Strategic issues
• Operational issues
• Opportunities
Provide for organizational learning
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
15
Our Organizational Structure
Operations Committee Activities:
Review functional, product and geographic plans
Align plans with corporate goals and targets
Monitor corporate performance
Debate strategic issues
Review succession plans
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
16
Global Pharmaceutical MarketEurope,
Middle Eastand Africa
31%
North America33%
Japan23%
Australia1%
Latin America
7%
Asia and Pacific5%
Sales: $134 Billion U.S. In 1999
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
17
External Factors Affecting the Industry
Demographics
Government/Individual Spending
Disease Focus
Decision Maker/Influencer
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
18
Internal Factors Affecting the Industry
Cost
Competition
Regulation
Product Risk
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
19
Pharmaceutical Research Spending
Global (R&D) spending was $24 billion U.S. in 1999
R&D as a percentage of sales was 18 percent
Much higher than other industries:
• 6.4 percent in electronics
• 3.9 percent in aerospace
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
20
Product Risk
10,000 Compounds
1,000 Show Promise
100 Are Tested
1
Average cost to develop one drug:
$500 Million U.S.
To Market
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
21
Product Life Cycle
15 years for R&Dand Product
Launch
Drug Discoveryand Development
5 Yearsto RecoverR&D costs
Launch
Generic Competition
Off Patent No Longer Manufactured
Patent Protection
20 years
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
22
Drug Development Process
Commercialization
ProductsPrograms
Candidate Development
Hypothesis Generation
Projects
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
23
Hypothesis Generation
Hypothesis Generation
Projects
• Target identification and validation
• Assay development
• Lead generation
Activities Goal
Testable,valuable hypothesis
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
24
Candidate Development
• Lead optimization
• First human dose preparation
• Phase IA clinical trials
• Phase IB / II clinical trials
Goal
Proven or disproven hypothesis for given drug candidate
ActivitiesCandidate Development
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
25
Commercialization
Commercialization
Products
• Phase III clinical trials
• Submission to regulatory agencies
• Global launch
• Global optimization
Goal
Successfulcommercial
product
Activities
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
26
Quality, Speed, Value
• Quality: Working on the best opportunities
• Speed: Develop drugs in half the time
• Value: Double the products for every R&D dollar
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
27
Targeted Research Categories
Cardiovascular
Central Nervous System
Endocrine
Infectious Diseases
Cancer
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
28
Current Products
More muscle
• Increase the sales force
• Visit more decision makers more frequently
• Publish more articles
New indications
• Increase direct marketing
Novel delivery devices
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
29
Product Development
New products
Product partnerships
• Research
• Launch
New combinations of existing products
• Depression
• Cancer
• Diabetes
• Sepsis
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
30
Bulk Manufacturing
A Pharmaceutical Company’s Manufacturing Processes
Raw pharmaceutical materials are made intoactive drug compounds.
Raw pharmaceutical materials are made intoactive drug compounds.
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
31
Formulation and Filling
Bulk Manufacturing
A Pharmaceutical Company’s Manufacturing Processes
Compounds are processed for storage and proper dosage. This could include:
• Mixing inert substances into compounds
• Compressing dry compounds into tablets
• Filling capsules with dry compounds
• Filling vials with liquids
• Freeze-drying liquids for longer storage
Compounds are processed for storage and proper dosage. This could include:
• Mixing inert substances into compounds
• Compressing dry compounds into tablets
• Filling capsules with dry compounds
• Filling vials with liquids
• Freeze-drying liquids for longer storage
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
32
Formulation and Filling
Bulk Manufacturing
Finishing (packaging)
A Pharmaceutical Company’s Manufacturing Processes
Products are preparedfor distribution by:
• Putting them in containers
• Labeling the containers
• Inserting patient instructions
• Placing the containers in bulk packaging
Products are preparedfor distribution by:
• Putting them in containers
• Labeling the containers
• Inserting patient instructions
• Placing the containers in bulk packaging
April 4,2000 Global New Employee Orientation Company ConfidentialCopyright © 2000 Eli A Pharmaceutical Company and Company
33
Introduction to Our Intranet
The Company Intranet
The Orientation Site links to:
• Employee benefits and services
• Corporate policies and procedures
• Functional business components
• A Pharmaceutical Company’s product portfolio
• Pharmaceutical industry overview
• Career development resources
34
Global New Employee Orientation Workshop
Thank You